CSG, Forges

CSG Forges US Artillery Push as Stock Climbs from June Trough, but Chart Resistance Looms

02.07.2026 - 18:17:24 | boerse-global.de

Czechoslovak Group shares surge on new US subsidiary targeting military contracts, but stock remains 62% below record and must break 50-day moving average to sustain recovery.

CSG Stock Jumps 8% on US Defense Expansion, Faces Key Resistance
CSG - CSG Forges US Artillery Push as Stock Climbs from June Trough, but Chart Resistance Looms 02.07.2026 - Bild: über boerse-global.de

Shares of Czechoslovak Group (CSG) jumped nearly 8 percent to €14.60 on Wednesday as investors cheered the defence company’s latest push into the American market. The move marks an extension of a fragile recovery: since hitting a 52-week low of €12.20 on 26 June, the stock has clawed back roughly 20 percent. Yet with the shares still trading 62 percent below the January 2026 record of €36.05, the rebound is testing technical barriers that will determine whether the uptrend can be sustained.

The catalyst for the latest buying came from CSG’s announcement that it had formed a new US subsidiary, CSG Land Systems North America, based in Michigan. The entity combines three long-standing NATO suppliers — Excalibur Army, Tatra Defence and Tatra Trucks — and will target the US military with mobile artillery systems and tactical vehicles. Central to the sales strategy is the fully automatic Morana artillery system, which CSG recently demonstrated to American military officials at the Detroit Arsenal. A key selling point: the weapon fires both US and NATO standard ammunition from a robust Tatra chassis.

The Michigan operation dovetails with production already underway in the US. Through its existing subsidiary MSM Group North America, CSG secured a major military contract in 2025 and is building a plant in Iowa capable of producing 36,000 155mm artillery shells per month. Collectively, the moves signal the company’s ambition to embed itself deeper into the Pentagon’s supply chain, a strategic pivot that markets have greeted with relief after a prolonged sell-off.

Despite the recent gains, the stock remains in a precarious position. The shares hover below the 50-day moving average of €16.10, a level that must be reclaimed to break the overarching downtrend. The relative strength index (RSI) stands at 39.8, still in bearish territory, while annualised volatility of 55.9 percent underscores the risk of sharp reversals. For now, the chart favours sellers until CSG can clear that average with conviction.

Should investors sell immediately? Or is it worth buying CSG?

Investor scepticism is rooted partly in the stock’s trajectory since its initial public offering in January 2026. What was meant to be a vote of confidence in the Czech defence group’s governance and global ambitions instead became a 60-percent-plus rout. In a statement on 30 June, CSG’s management sought to counter the narrative, arguing that the IPO delivered more than a trading venue: it boosted international visibility, strengthened governance credentials, and eased recruitment of top talent from global defence and industrial giants. The company now employs more than 14,000 people and runs production sites across Europe, the US and Asia.

Fundamentally, the growth story retains its backbone. First-quarter 2026 revenue rose 13.8 percent year-on-year to €1.544 billion, while operating EBIT climbed 8.7 percent to €372 million, driving a margin of 24.1 percent. The order book swelled 15.1 percent to €17 billion by the end of 2025, with a further pipeline of €27 billion in negotiations. Management reaffirmed its full-year guidance for revenue between €7.4 billion and €7.6 billion, an EBIT margin of roughly 24-25 percent, and capital expenditure of approximately 8.5 percent of sales. The defence systems division — covering land systems, medium and large-calibre ammunition — accounted for €1.251 billion in Q1 revenue, up 26.5 percent, and an operating margin of 28.4 percent.

Ammunition capacity remains a critical operational focus. CSG has already expanded large-calibre shell output to more than 800,000 units and expects to reach 850,000 by year-end 2026 based on existing orders. The management says growth will be driven primarily by land systems and munitions, supported by a recovery in the US Ammo+ business.

CSG at a turning point? This analysis reveals what investors need to know now.

The next major test for the stock will come in August with the release of the half-year results, following a quiet period in July when no fresh financial updates are expected. The 30 June communication did not alter the company’s financial guidance, but it served as an important signal that CSG wants investors to see it as an international defence platform, not a regional industrial player. Whether improved governance and a broader leadership team can translate the €17 billion order book into cash flows — and finally lift the stock above its technical ceiling — is the question the August report will aim to answer.

Ad

CSG Stock: New Analysis - 2 July

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSG | boerse | 69674808 |